Preventing cognitive decline and unemployment in people with multiple sclerosis
Official title: Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis
Run by Amsterdam UMC, location VUmc · NCT06068582 · Data updated 2026-11-12
This study is testing two new programs to see if they can help people with multiple sclerosis keep their thinking skills sharp and stay employed, compared to regular care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 67 Years |
| Sex | All |
| Enrollment | 270 (estimated) |
| Sponsor | Amsterdam UMC, location VUmc Academic / other |
| Locations | 1 site (Amsterdam) |
| Status | Recruiting |
| Started | April 16, 2023 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | April 3, 2025 |
| Trial ID | NCT06068582 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 67 with a confirmed diagnosis of multiple sclerosis and mild cognitive deficits.
✕Probably not a fit
Patients with severe cognitive impairments or other neurological and psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial aims to evaluate the effectiveness of two innovative interventions designed to prevent cognitive decline and work-related issues in individuals with multiple sclerosis (MS) compared to enhanced usual care. Participants will engage in interventions focused on strengthening cognitive and psychological functions over a four-month period, with follow-up assessments at six and twelve months post-intervention. The study will also explore predictive factors for intervention response and gather qualitative feedback from stakeholders to facilitate clinical implementation.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life for individuals with multiple sclerosis by delaying cognitive decline and enhancing employment outcomes.
How similar studies have gone: Previous studies have shown promise in using cognitive and psychological interventions for individuals with multiple sclerosis, but this specific approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed MS diagnosis according to the McDonald 2017 criteria * Age between 18 and 67 * No changes in disease modifying therapy prior to inclusion (i.e., no changes in last 3 months) - this criterion only applies at inclusion to ensure participants are in a stable situation at the start of the study and for follow-up measures, changes in treatment will be registered but will not result in exclusion from the study * no current relapse or steroid treatment in the six weeks prior to study visits * presence of mild cognitive deficits (at least one test with a Z-score of -1.0 to -1.99 below norm scores of healthy controls on the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery * being able to participate in an exercise intervention (i.e., EDSS \< 6.0) * fulfilling safety criteria for MRI (no metal inside body, not pregnant, no claustrophobia) Exclusion Criteria: * presence of neurological (other than MS) and psychiatric disorders * a current or history of drug or alcohol abuse * being unable to speak or read Dutch * currently on sick leave for a period of 6 weeks or longer * currently pregnant
Where it's running
-
Amsterdam University Medical Centers, location VUmc
Amsterdam, Netherlands Recruiting
Study contacts
- Principal investigator: Hanneke E Hulst — Leiden University
- Study coordinator: Jip Aarts
- Email: j.aarts@fsw.leidenuniv.nl
- Phone: +31 71 5275081
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.